CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 93 filers reported holding CYTOKINETICS INC in Q1 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $4,957,000 | +84.8% | 409,679 | +96.2% | 0.36% | +93.0% |
Q1 2017 | $2,682,000 | -32.1% | 208,781 | -44.7% | 0.19% | -34.2% |
Q4 2015 | $3,951,000 | +173.0% | 377,801 | +74.6% | 0.28% | +175.7% |
Q3 2015 | $1,447,000 | +86.7% | 216,368 | +87.5% | 0.10% | +77.6% |
Q2 2015 | $775,000 | +258.8% | 115,379 | +261.1% | 0.06% | +286.7% |
Q1 2015 | $216,000 | -80.8% | 31,949 | -90.0% | 0.02% | -79.5% |
Q3 2014 | $1,125,000 | -57.4% | 319,647 | -42.2% | 0.07% | -58.8% |
Q2 2014 | $2,643,000 | -21.4% | 553,008 | +56.1% | 0.18% | -23.4% |
Q1 2014 | $3,364,000 | -0.6% | 354,180 | -20.8% | 0.23% | -32.7% |
Q3 2013 | $3,384,000 | – | 447,035 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |